Lupus Core Dataset for Research jjcush@gmail.com Mon, 08/25/2025 – 15:24 Read More
RheumNow
Physical Therapy Underprescribed jjcush@gmail.com Mon, 08/25/2025 – 15:21 Read More
Study of 90 Still’s Dz pts w/ lung disease from AIDA network – mean age 36 yr;… Read More
It’s now called Sjögren Disease! Sjögren syndrome is now Sjögren disease, according to recommendations stemming fro https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg… Read More
Biologics and Biosimilars Global Market size was valued at~ $478.83 Billion USD in 2024; expected to reach… Read More
AbbVie announces positive topline results from a 2nd Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata… Read More
https://t.co/nk6sBThX0v https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 08/24/2025 – 10:00 RheumNow Dr. John Cush https://t.co/nk6sBThX0v 24-08-2025 https://pbs.twimg.com/media/GzH1Cv1WYAAUAfA.jpg Read More
FDA has granted Soligenix “Orphan Drug Designation” to study dusquetide in the treatment of Behçet’s dz, based… Read More
Single-center Retrospective study of 4,736 RA, propensity matched 509 w/ RA-ILD vs 509 without ILD. In multivariate… Read More
Telitacicept, a BLyS (BAFF)/APRIL dual-target fusion drug, announced it has met the primary endpoint in its Phase… Read More